SCHEMBL172767

SCHEMBL172767

CNc1cc(Cl)cnc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.40
▸ HCAR2 Q8TDS4 1/20 0.39
▸ KDM4C Q9H3R0 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ GPR27 Q9NS67 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ HCAR3 P49019 1/20 0.36
▸ NNMT P40261 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21339535 0.84 SCN9A (0.37) DHODHLMNAL3MBTL1KDM4EALDH1A1
SCHEMBL14305542 0.81 GAA (0.39) LMNAL3MBTL1KDM4EALDH1A1GLA
SCHEMBL14303603 0.81 NR4A1 (0.48) DHODHKDM4CLMNAALDH1A1GAA
SCHEMBL287761 0.79 LMNA (0.47) HCAR2LMNAL3MBTL1ALDH1A1GLA
SCHEMBL14076853 0.79 ALDH1A1 (0.39) HCAR2KDM4CKDM4EALDH1A1HCAR3
SCHEMBL12079620 0.79 AGBL2 (0.40) HCAR2KDM4CKDM4EALDH1A1HCAR3
SCHEMBL23413510 0.77 LMNA (0.46) HCAR2LMNAL3MBTL1ALDH1A1GLA
Hydrochloric Acid SCHEMBL20139726 0.77 LMNA (0.46) HCAR2LMNAL3MBTL1ALDH1A1GLA
SCHEMBL287320 0.76 HCAR2 (0.42) DHODHHCAR2LMNAL3MBTL1KDM4E
SCHEMBL15268202 0.76 RECQL (0.42) DHODHLMNAALDH1A1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2175859-B1 FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREAMENT OF INFLAMMATION CHEMOCENTRYX INC (US) 2012-03-07 — — EP disclosed
Send feedback